Updates and Q&A
|A COVID-19 Update.||3:14|
|Impact of COVID-19 on Patients Living with Vasculitis survey report||7:01|
|Vasculitis Community’s Feelings on the Flu and COVID-19 Vaccine Report||9:29|
|Is there a situation where you would advise a patient with vasculitis to not get the COVID-19 vaccine?||15:38|
|Should I hold my methotrexate treatment if I’m also getting the COVID-19 vaccine?||18:59|
|What about the timing between my Rituximab infusion, and when I get the vaccine?||21;45|
|Should I still wear a mask even after I get the vaccine?||28:53|
|Are there any concerns about the use of mRNA technology as opposed to other vaccine delivery platforms?||33:27|
|Is there an advantage of getting one type of vaccine over another one?||37:35|
|Have these vaccines been tested on patients with vasculitis?||41:38|
|Should I get an antibody test for COVID-19?||42:43|
More Patient Questions About COVID-19
Kenneth J. Warrington, M.D.
Chair, Division of Rheumatology, Professor of Medicine, Mayo Clinic
In this webinar, Dr. Ken Warrington, answers some of the patient questions about COVID-19 that weren’t included in the live, February 27 webinar. Among the discussion highlights is Kathy’s story about catching COVID-19 as a patient with vasculitis. Dr. Warrington also provides insight into the key questions being researched about the virus, and the vaccine.